Pro Dex Inc financial data

Symbol
PDEX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2361 Mcgaw Avenue, Irvine, CA
Fiscal year end
June 30
Latest financial report
10-Q - Q4 2024 - Jan 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 300 % -12.1%
Quick Ratio 127 % -22.7%
Debt-to-equity 74.9 % +16.4%
Return On Equity 21.7 % +125%
Return On Assets 12.4 % +111%
Operating Margin 16.8 % +29.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.26M shares -7.13%
Common Stock, Shares, Outstanding 3.26M shares -7.93%
Entity Public Float 35.5M USD +9.23%
Common Stock, Value, Issued 366K USD -94.8%
Weighted Average Number of Shares Outstanding, Basic 3.26M shares -8.06%
Weighted Average Number of Shares Outstanding, Diluted 3.34M shares -7.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 61M USD +26.4%
Cost of Revenue 42.7M USD +23.3%
Research and Development Expense 3.38M USD +12.7%
General and Administrative Expense 4.51M USD +6.22%
Operating Income (Loss) 10.3M USD +63.4%
Nonoperating Income (Expense) 485K USD -52.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.75M USD +119%
Income Tax Expense (Benefit) 2M USD +102%
Net Income (Loss) Attributable to Parent 6.75M USD +125%
Earnings Per Share, Basic 2.03 USD/shares +139%
Earnings Per Share, Diluted 1.99 USD/shares +137%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66K USD -94.9%
Marketable Securities, Current 4.67M USD +512%
Accounts Receivable, after Allowance for Credit Loss, Current 18.5M USD +40.2%
Inventory, Net 19.6M USD +30.5%
Assets, Current 44.3M USD +21%
Deferred Income Tax Assets, Net 1.56M USD
Property, Plant and Equipment, Net 6.11M USD +14.6%
Operating Lease, Right-of-Use Asset 1.27M USD -24.5%
Intangible Assets, Net (Excluding Goodwill) 40K USD -41.2%
Other Assets, Noncurrent 44K USD +4.76%
Assets 60.4M USD +17.4%
Accounts Payable, Current 5.69M USD +95.6%
Accrued Liabilities, Current 5.23M USD +83.9%
Liabilities, Current 17.1M USD +71.6%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 939K USD -33.6%
Liabilities 28.6M USD +45.4%
Retained Earnings (Accumulated Deficit) 31.5M USD +27.3%
Stockholders' Equity Attributable to Parent 31.8M USD +0.11%
Liabilities and Equity 60.4M USD +17.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.89M USD +381%
Net Cash Provided by (Used in) Financing Activities -1.01M USD +22.5%
Net Cash Provided by (Used in) Investing Activities -431K USD -242%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 3.26M shares -7.93%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66K USD -94.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 162K USD +15.7%
Deferred Tax Assets, Valuation Allowance 90K USD -1.1%
Deferred Tax Assets, Gross 3.38M USD +8.93%
Operating Lease, Liability 1.42M USD -23.5%
Depreciation 23K USD 0%
Payments to Acquire Property, Plant, and Equipment 431K USD +242%
Lessee, Operating Lease, Liability, to be Paid 1.53M USD -25.6%
Property, Plant and Equipment, Gross 6.5M USD
Operating Lease, Liability, Current 476K USD +9.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 551K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 269K USD -49.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 115K USD -44.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 567K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 23K USD +4.55%
Unrecognized Tax Benefits 262K USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 143K USD 0%
Operating Lease, Payments 526K USD +2.73%
Depreciation, Depletion and Amortization 302K USD +6.71%
Deferred Tax Assets, Net of Valuation Allowance 3.29M USD +9.24%
Interest Expense 204K USD +46.8%